Eicosapentaenoic Acid and the Outcomes in Older Patients Undergoing Atrial Fibrillation Ablation.
Yuya SudoTakeshi MorimotoRyu TsushimaAkihiro OkaMasahiro SogoMasatomo OzakiMasahiko TakahashiKeisuke OkawaPublished in: Journal of the American Heart Association (2024)
The EPA/AA was associated with AF recurrence and MACE after ablation in patients with AF aged ≥65 years.
Keyphrases
- atrial fibrillation
- catheter ablation
- patients undergoing
- left atrial
- left atrial appendage
- oral anticoagulants
- direct oral anticoagulants
- heart failure
- radiofrequency ablation
- physical activity
- percutaneous coronary intervention
- middle aged
- community dwelling
- type diabetes
- adipose tissue
- coronary artery disease
- insulin resistance
- glycemic control
- left ventricular